Biodesix, Inc.
BDSX
$0.8622
$0.01221.44%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 48.92% | 46.25% | 34.70% | 28.46% | 22.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.92% | 46.25% | 34.70% | 28.46% | 22.88% |
| Cost of Revenue | 12.85% | 2.32% | -7.61% | -8.08% | -2.99% |
| Gross Profit | 63.93% | 66.97% | 57.08% | 49.96% | 38.22% |
| SG&A Expenses | 12.87% | 6.80% | 4.53% | 9.64% | 16.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.39% | 0.66% | -2.63% | 1.88% | 9.80% |
| Operating Income | 28.51% | 36.00% | 31.60% | 18.23% | -0.10% |
| Income Before Tax | 30.82% | 32.66% | 31.37% | 20.32% | -8.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.82% | 32.66% | 31.37% | 20.32% | -8.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.82% | 32.66% | 31.37% | 20.32% | -8.48% |
| EBIT | 28.51% | 36.00% | 31.60% | 18.23% | -0.10% |
| EBITDA | 35.11% | 41.04% | 34.83% | 19.06% | -0.79% |
| EPS Basic | 56.19% | 58.09% | 59.03% | 59.45% | 48.12% |
| Normalized Basic EPS | 52.97% | 55.56% | 54.10% | 55.34% | 49.70% |
| EPS Diluted | 56.19% | 58.09% | 59.03% | 59.45% | 48.12% |
| Normalized Diluted EPS | 52.97% | 55.56% | 54.10% | 55.34% | 49.70% |
| Average Basic Shares Outstanding | 57.58% | 55.73% | 61.53% | 94.77% | 113.17% |
| Average Diluted Shares Outstanding | 57.58% | 55.73% | 61.53% | 94.77% | 113.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
